Skip to main content
HIMS
NYSE Life Sciences

FDA Panel on Peptide Compounding Set for July 23-24, Critical for Hims' GLP-1 Business

Tom Rudovsky · Reported by Wiseek News
More coverage: Household Product Stocks · Consumer
Sentiment info
Neutral
Importance info
7
Price
$32.47
Mkt Cap
$7.571B
52W Low
$13.74
52W High
$70.43
52W Position info
136% above low
Off High info
54% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

HIMS has more than doubled off its 52-week low of $13.74.

Summary

An FDA panel is scheduled for July 23-24 to discuss adding peptides to 503A, a regulatory decision critical for Hims & Hers Health's compounded GLP-1 product offerings. This follows earlier news on April 16th regarding the FDA's general consideration of easing restrictions on compounding pharmacies for peptides, now with a specific date for review. Separately, analysts raised price targets for HIMS, with Barclays to $39 and Leerink to $25. The outcome of the July FDA panel will be a key factor to watch for the company's weight loss segment.

At the time of this announcement, HIMS was trading at $32.47 on NYSE in the Life Sciences sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $13.74 to $70.43. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

HIMS - Latest Insights

HIMS
Nov 11, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $15.32 info
Change: -$3.68 (-19%) info
Market Cap: $3.578B info
HIMS
Nov 10, 2026, 1:54 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $18.85
Real-time Price: $15.32 info
Change: -$3.52 (-19%) info
Market Cap: $3.578B info
HIMS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $22.16
Real-time Price: $15.32 info
Change: -$6.84 (-31%) info
Market Cap: $3.578B info
HIMS
Nov 09, 2026, 5:52 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.33
Real-time Price: $15.32 info
Change: -$7.01 (-31%) info
Market Cap: $3.578B info
HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $15.32 info
Change: -$8.07 (-35%) info
Market Cap: $3.578B info